StemoniX
Edit

StemoniX

http://www.stemonix.com/
Last activity: 12.01.2021
Categories: BioTechDeliveryDevelopmentDrugGovTechHumanMedtechProductResearchService
Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at info@stemonix.com to discuss how StemoniX products and services can accelerate your discoveries.
Followers
432
Mentions
7
Location: United States, Minnesota, Maple Grove
Employees: 11-50
Total raised: $14.4M
Founded date: 2014

Investors 6

Funding Rounds 1

DateSeriesAmountInvestors
01.03.2019Series B$14.4M-

Mentions in press and media 7

DateTitleDescriptionSource
12.01.2021StemoniX to Participate in Biotech Showcase(TM) Digital 2021Maple Grove, Minnesota--(Newsfile Corp. - January 11, 2021) - StemoniX, a biotech company changing h...marketscre...
14.08.2020Canada’s Atomwise secures 163M CAD in Series B fundingThe AI-driven drug discovery platform was founded in 2012 by Abraham Heifets, Alexander Levy and Dr....vcbay.news...
01.03.2019Term Sheet — Friday, March 1PAYING UP FOR CYBERSECURITY Good morning, Term Sheet readers. Paid Content What you need to know abo...fortune.co...
01.03.2019Daily funding roundup - March 1st, 2019Odaseva raised $11.7M; StemoniX raised $14.4M; Bandier raised $34.4M; Jet Edge raised $60M Odaseva: ...vator.tv/n...
28.02.2019StemoniX Secures $14.4M in Series B FundingStemoniX Inc., a Maple Grove, Minn.-based biotech company, secured $14.4m USD in Series B funding. T...finsmes.co...
28.02.2019StemoniX Nabs $14.4M Series B MAPLE GROVE, MN, StemoniX announced today that it has secured $14.4 million in Series B funding. ...vcnewsdail...
04.06.2018Digital Manufacturing and LogisticsLegacy Manufacturing Hubs Manufacturing and farming ecosystems in the US and around the world have d...greatnorth...

Reviews 0

Sign up to leave a review

Sign up Log In